Isoray and University of Cincinnati Physicians Company Sign Research Agreement to Study Treatment of Head and Neck Cancers
The planned trial will evaluate the safety and early effectiveness of the addition of pembrolizumab (Keytruda) to the regimen of Cesium-131 with surgical resection.
